Resource Center

Regulatory Updates
2023 Drug Wastage Rule Impacts Manufacturers

2023 Drug Wastage Rule Impacts Manufacturers

2023 DRUG WASTAGE RULE TO IMPACTPHARMA MANUFACTURERSPharmaceutical manufacturers continue to experience regulatory and program changes that result in new rebates and/or penalties which have the potential to negatively impact profitability. Last year, the Inflation...

IRA Rebate Provisions for Pharma Manufacturers

IRA Rebate Provisions for Pharma Manufacturers

Update – Inflation Reduction Act Rebate Provisions for Pharma ManufacturersInflation Reduction Act – new updates! On August 16th, 2022, the Inflation Reduction Act (IRA) of 2022 was signed into law, creating potential impacts for drug manufacturers in the way of...

CMS Enforcement for ASP in Medicare Part B

CMS Enforcement for ASP in Medicare Part B

CMS Enforcement of Average Sales Price (ASP) Submissions for all Medicare Part B Eligible Pharmaceuticals and BiopharmaceuticalsRecently, CMS has been sending letters to pharma and biopharma manufacturers (with and without MDRP agreements) indicating that they believe...